Kissei Pharmaceutical, which sells the rare immune-disease drug in Japan, warned doctors to stop prescribing it to new patients.

Travellers headed to Japan may have heightened safety concerns after a magnitude 6.7 earthquake struck off the coast of the Miyagi region on Friday. Although no tsunami warnings have been issued, the UK Foreign Office (FCDO) tells tourists to “follow the advice of local authorities” in the event of a disaster in the major earthquake zone.

An earthquake with a magnitude of 7.4 struck off Japan's northern coast, prompting a temporary tsunami alert across the region.

By Rocky Swift TOKYO, May 14 (Reuters) - Bain Capital-owned Tanabe Pharma plans to bring up to three new drugs to Japan each year as the former Mitsubishi Chemical unit doubles down on its home market,

Japan's wholesale inflation accelerated in April at the fastest pace in three years as the Iran war boosted oil and chemical goods prices, data showed on

Third long-term decarbonization auction sees significant drop in BESS bids due to new rule on storage duration. However, awarded capacity for battery storage remained relatively strong.

May 15 (Reuters) - About 20 deaths linked to serious liver dysfunction have been reported in Japan in patients treated with Amgen's rare disease drug Tavneos, according to a safety notice issued by partner Kissei Pharmaceutical on Friday.

An Indian restaurant owner in Japan broke down at an event while opening up about fears of being deported due to the newly tightened Japanese business visa requirements. Manish Kumar, who lived in Japan for over 30 years, questioned the rule and its impact while speaking at a gathering about the visa issue on May 13.